Karo Pharma AB (publ)
Karo Pharma AB (publ) (KARBF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KARBF · as of Jun 8, 2026
Key Statistics
Explore Karo Pharma AB (publ) Data
karbf stock data · financialsCompetitors & Peers
karbf competitorsKARBF
BIESF
BITGF
CMPUY
CMPVF
CSWYFStock Performance
Full HistoryAbout Karo Pharma AB (publ)
Karo Pharma AB (publ) develops and markets prescription drugs and over-the-counter products for pharmacies and retail sector in Sweden, Norway, Denmark, Finland, France, Germany, Italy, rest of Europe…
what is karo pharma ab (publ) · karbf stock overview · karo pharma ab (publ) company profile · who is karo pharma ab (publ) ceo · karbf OTC · karo pharma ab (publ) headquarters · karo pharma ab (publ) business segments
About Stock Overview & Key Data
Karo Pharma AB (publ) (KARBF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Apr 30, 2013. As of the latest trading session, KARBF stock price is $5.25, with a market capitalization of $1.5B. The stock has returned -8.04% over the past 12 months and +0.00% year-to-date.
Frequently Asked Questions
As of the latest trading session, Karo Pharma AB (publ) (KARBF) stock price is $5.25. The stock is traded on OTC under the ticker symbol KARBF. The 52-week range is $5.25 – $5.71.